These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2327765

  • 21. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
    Hirschhorn L, Neu HC.
    Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC, Chang SC, Hsu LY, Hsieh WC, Luh KT.
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F.
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J.
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of T-3761, a new fluoroquinolone.
    Muratani T, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
    [Abstract] [Full Text] [Related]

  • 37. E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.
    Guinea J, Gargallo-Viola D, Robert M, Tudela E, Xicota MA, Garcia J, Esteve M, Coll R, Pares M, Roser R.
    Antimicrob Agents Chemother; 1995 Feb; 39(2):413-21. PubMed ID: 7726507
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.
    Verbist L, Verhaegen J.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):222-5. PubMed ID: 6289726
    [Abstract] [Full Text] [Related]

  • 39. Fleroxacin combined with rifampin.
    Zhang YX, Neu HC.
    Diagn Microbiol Infect Dis; 1991 Feb; 14(1):23-7. PubMed ID: 1901534
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.